TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scandinavian ChemoTech AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
6,772
|
2,859
|
447 |
| Financial expenses |
1,215
|
1,421
|
1,794 |
| Earnings before taxes |
-14,146
|
-21,366
|
-21,516 |
| EBITDA |
-11,069
|
-17,786
|
-16,992 |
| Total assets |
13,799
|
15,063
|
20,527 |
| Current assets |
8,013
|
7,292
|
11,179 |
| Current liabilities |
7,632
|
3,888
|
7,292 |
| Equity capital |
6,167
|
11,175
|
13,235 |
| - share capital |
12,037
|
9,086
|
5,682 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
44.7%
|
74.2%
|
64.5% |
| Turnover per employee |
1,129
|
476
|
74 |
| Profit as a percentage of turnover |
-208.9%
|
-747.3%
|
-4813.4% |
| Return on assets (ROA) |
-93.7%
|
-132.4%
|
-96.1% |
| Current ratio |
105.0%
|
187.6%
|
153.3% |
| Return on equity (ROE) |
-229.4%
|
-191.2%
|
-162.6% |
| Change turnover |
3,861
|
2,380
|
401 |
| Change turnover % |
133%
|
497%
|
865% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-14% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.